Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:PEAR

Pear Therapeutics (PEAR) Stock Price, News & Analysis

Pear Therapeutics logo

About Pear Therapeutics Stock (NASDAQ:PEAR)

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
66.30 million shs
Average Volume
7.75 million shs
Market Capitalization
$4.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

Receive PEAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pear Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

PEAR Stock News Headlines

“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.
See More Headlines

PEAR Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Pear Therapeutics investors own include Meta Platforms (META), LyondellBasell Industries (LYB), AbCellera Biologics (ABCL), Atai Life Sciences (ATAI), CVS Health (CVS), uniQure (QURE) and Absci (ABSI).

Company Calendar

Today
11/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Current Symbol
NASDAQ:PEAR
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

Net Income
$-75,490,000.00
Net Margins
-594.70%
Pretax Margin
-594.70%

Debt

Sales & Book Value

Annual Sales
$12.69 million
Book Value
$0.22 per share

Miscellaneous

Free Float
98,918,000
Market Cap
$4.17 million
Optionable
Not Optionable
Beta
0.45
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NASDAQ:PEAR) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners